Tirzepatide Dosing Units and Reconstitution: mg, Units, and the Math

Tirzepatide's dosing looks simple on paper: six numbers, 2.5 through 15 mg, stepped up once every few weeks. Where it gets confusing is the moment a vial, a bottle of bacteriostatic water, and a U-100 insulin syringe all show up on the same bench. The vial says milligrams. The syringe says units. A calculator might ask for micrograms. None of those numbers are interchangeable without a calculation in between, and that calculation, not the dosing schedule itself, is where most measurement mistakes happen.

This is a complete walkthrough of that calculation for tirzepatide specifically: what mg, mcg, and units each measure, how the SURMOUNT-1 titration schedule actually moved through those six doses, how reconstitution concentration turns a milligram target into a syringe reading, and worked charts for common vial sizes. It is written for research and educational purposes. It reports trial and measurement information; it is not medical advice, and tirzepatide is not approved outside its regulated pharmaceutical indications.

Tirzepatide's units: mg, mcg, and syringe units are not the same kind of number

Three different "units" show up across a tirzepatide protocol, and only two of them measure the same kind of thing.

Milligrams and micrograms are both mass, separated by a clean factor of 1000: 1 mg equals 1000 mcg. ^[3] Tirzepatide's labeled strengths, 2.5, 5, 7.5, 10, 12.5, and 15 mg, are identical amounts to 2500, 5000, 7500, 10000, 12500, and 15000 mcg. Writing "5000 mcg" instead of "5 mg" changes nothing about the peptide involved, only the number used to describe it, and mixing the two up in a calculation is a 1000-fold error waiting to happen. ^[4]

Units are a different category entirely. A U-100 insulin syringe is built so that 100 units equal exactly 1 mL of liquid, whatever that liquid is. ^[5] A unit mark, in other words, measures how much fluid has been drawn, not how much peptide is dissolved in it. That distinction is the entire reason "how many units is a 5 mg tirzepatide dose" has no single answer until you know the concentration.

The SURMOUNT-1 titration schedule: 2.5 mg to 15 mg

Tirzepatide's Phase 3 obesity trial, SURMOUNT-1, did not start anyone at a high dose. ^[1] Participants began at 2.5 mg once weekly, a dose the trial used specifically to ease the gastrointestinal adjustment period rather than to drive weight loss on its own, then stepped up by 2.5 mg increments roughly every four weeks until reaching an assigned target of 5, 10, or 15 mg once weekly.

Lower-target arms simply stopped climbing earlier: the 5 mg arm held at 5 mg after its first four-week step, the 10 mg arm held after reaching 10 mg. ^[1] The 2.5 mg step is why "tirzepatide's lowest dose" and "tirzepatide's starting dose" are the same number, 2.5 mg, even though the trial's efficacy data is reported at the 5, 10, and 15 mg targets.

The dose-response is orderly, each step up in target produced more mean loss, and the gap between 10 mg and 15 mg (5.9 percentage points) is narrower than the gap between 5 mg and 10 mg (4.5 percentage points), which is the same pattern of narrowing marginal return seen at the top of most titrated GLP-1/GIP dose ranges. ^[1] The full retatrutide-versus-tirzepatide comparison puts these figures next to the triple-agonist data if you're weighing the two.

The four-week spacing behind that schedule is not arbitrary. Tirzepatide's elimination half-life is approximately 5 days, long enough that a single dose keeps accumulating in plasma for three to four weeks before reaching its own steady state, so raising the dose again before that plateau stacks a new increase on top of one still building. ^[2] The same roughly 5-day half-life is why weekly dosing is sensible in the first place: plasma levels between injections never fall far. The full rationale, and how the escalation manages GI tolerability step by step, is covered in tirzepatide dosing and titration; this guide focuses on what happens once a dose is chosen, at reconstitution and on the syringe.

How concentration turns a tirzepatide vial into a syringe reading

Reconstitution is the step where a fixed amount of peptide, the milligrams in the vial, becomes a measurable liquid. The concentration you create at that moment is the only thing that connects a milligram target to a number on the syringe barrel.

Concentration (mg/mL) equals milligrams of peptide in the vial divided by milliliters of bacteriostatic water added.

The peptide mass in the vial never changes. Only the volume it is dissolved in does, and that volume is entirely your choice at reconstitution. (The mechanics of the reconstitution itself, adding water down the vial wall, swirling rather than shaking, dating the label, are covered step by step in how to reconstitute peptides with bacteriostatic water; a fresh alcohol prep pad and a sterile needle for each puncture are the two supplies that step assumes are on hand.)

Once the concentration is set, converting a target dose to a syringe reading is two steps:

1. Volume needed (mL) equals target dose (mg) divided by concentration (mg/mL).
2. Units equal volume (mL) multiplied by 100, because a U-100 syringe reads 100 units per 1 mL.

Worked at 20 mg/mL, a 5 mg dose is 5 divided by 20, which is 0.25 mL, and 0.25 times 100 is 25 units. That is the entire calculation; everything below is the same two steps applied to different numbers.

Tirzepatide dosage in units: worked chart at two common concentrations

The clearest way to see why "tirzepatide units to mg" has no single fixed answer is to hold the six dose strengths constant and change only the concentration. Below is every labeled dose worked at two realistic reconstitution choices: a 40 mg vial in 2 mL of bacteriostatic water (20 mg/mL) and a 20 mg vial in 2 mL (10 mg/mL).

Read any row across and two things stand out. The same milligram dose is exactly double the unit count at 10 mg/mL that it is at 20 mg/mL, since the concentration is exactly half. And at 10 mg/mL, the 12.5 mg and 15 mg doses read as 125 and 150 units, both past the 100-unit capacity of a standard 1 mL syringe, a sign the prep is too dilute for that dose rather than a measurement error, and why 20 mg/mL is the more practical choice at the higher end of the range.

The half-unit readings at 20 mg/mL (12.5, 37.5, 62.5 units) are also worth flagging: many U-100 syringes tick every 2 units, not every 1, so a half-unit target sits between the visible marks. A finer-tick syringe, or a concentration chosen so doses land on whole units, removes the ambiguity.

Reading a U-100 syringe correctly

A standard 1 mL U-100 syringe is numbered 0 to 100, with a labeled line every 10 units and smaller ticks in between. Two habits keep a tirzepatide reading accurate:

• Read the barrel in units first, then convert to mg using the concentration written on the vial. The syringe cannot display milligrams directly; it only shows how far the plunger has been drawn.
• Confirm the tick spacing before assuming a reading. If the smallest tick is 2 units, a target that falls on an odd or half number sits between two visible marks, not on one, and needs either a finer syringe or a recalculated concentration.

Smaller-barrel syringes, a 0.5 mL / 50-unit or 0.3 mL / 30-unit design, spread the same U-100 calibration over a shorter barrel, making small volumes easier to read precisely; they still read 100 units per 1 mL, they simply top out lower, which suits the low end of tirzepatide's dose range well.

Common tirzepatide dosing and measurement mistakes

• Treating a unit count as a fixed dose. 25 units is 5 mg only at 20 mg/mL; a later vial reconstituted with a different amount of water turns the same 25-unit draw into a different milligram amount.
• Confusing mg and mcg. They are exactly 1000 apart, and misreading one for the other is a 1000-fold error, not a rounding difference. ^[4]
• Skipping the concentration label. An unlabeled vial forces a guess about what a given unit reading means; writing mg per mL on the vial at reconstitution removes the guesswork later.
• Reconstituting too dilute for the target dose. A 10 mg/mL prep pushes the 12.5 and 15 mg doses past what a standard 1 mL syringe holds, while a more concentrated prep keeps the full range inside one syringe.
• Misjudging tick spacing. A half-unit or odd-unit target on a syringe with 2-unit ticks is a between-the-lines read, not a rounding call.
• Compressing the titration. The four-week step spacing gives each dose time to reach steady state before the next increase stacks on top of it. ^[2]

Where a reconstitution calculator fits

The arithmetic above is two divisions and a multiplication, simple enough to do by hand, and doing it by hand at least once is worth the exercise. But because the failure modes are slips, a dropped decimal, a swapped mg for mcg, a calculator that takes the vial size, the water volume, and the target dose and returns the volume and unit reading is a useful cross-check. The store's peptide reconstitution calculator does exactly this conversion. The reliable habit either way is to compute forward, then check backward: if a calculator returns 25 units for a 5 mg dose at 20 mg/mL, confirm that 25 units, 0.25 mL, times 20 mg/mL really does equal 5 mg. When the forward and reverse math agree, a decimal error or a mg/mcg swap has nowhere left to hide.

For research and educational purposes only. Not medical advice. Dose figures, titration schedules, and unit conversions describe published clinical studies and current labeling, and standard measurement arithmetic, reported here as information, not as personal dosing instructions. Consult primary sources and a qualified professional for any medical decision.